These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 13750705)

  • 1. Ability of isopregnenolone-21-carboxylates to block renal effects of deoxycorticosterone and aldosterone in rats.
    KAGAWA CM; BROWN EA
    Proc Soc Exp Biol Med; 1960 Dec; 105():648-50. PubMed ID: 13750705
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology of a new steroid that blocks salt activity of aldosterone and desoxycorticosterone.
    KAGAWA CM; STURTEVANT FM; VAN ARMAN CG
    J Pharmacol Exp Ther; 1959 Jun; 126(2):123-30. PubMed ID: 13665517
    [No Abstract]   [Full Text] [Related]  

  • 3. Separate effects of aldosterone, DOCA, and methylprednisolone on renal Na-K-ATPase,
    Charney AN; Silva P; Besarab A; Epstein FH
    Am J Physiol; 1974 Aug; 227(2):345-50. PubMed ID: 4277648
    [No Abstract]   [Full Text] [Related]  

  • 4. STEROIDAL ALDOSTERONE BLOCKERS. VII.
    BROWN EA; BURTNER RR
    J Med Chem; 1963 Nov; 6():732-5. PubMed ID: 14184935
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the renal effects of the spirolactone, SC 9420, in man].
    ROMANI JD; KELLER A
    Sem Hop Ther Paris; 1962 Apr; 38():332-7. PubMed ID: 14493539
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE MECHANISM OF POTASSIUM-EXCRETORY ACTION OF HYDROCHLOROTHIAZIDE (HCT)].
    SU HT; KOO HY
    Sheng Li Xue Bao; 1964 Mar; 27():26-32. PubMed ID: 14184584
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of an aldosterone antagonist on the renal response to sodium restriction.
    ROSS EJ; WINTERNITZ WW
    Clin Sci; 1961 Feb; 20():143-8. PubMed ID: 13743603
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of spironolactone in modifying the renal electrolyte effects of hydrochlorothiazide in laboratory animals.
    KAGAWA CM; DRILL VA
    Arch Int Pharmacodyn Ther; 1962 Apr; 136():283-90. PubMed ID: 14453072
    [No Abstract]   [Full Text] [Related]  

  • 9. The blocking by spirolactones of the actions of aldosterone and cortisol upon the human kidney.
    MILLS JN; THOMAS S; WILLIAMSON KS
    J Endocrinol; 1962 Jan; 23():357-63. PubMed ID: 14474191
    [No Abstract]   [Full Text] [Related]  

  • 10. 5 alpha-Dihydro-11-deoxycorticosterone as a mineralocorticoid agonist and antagonist: evidence for a weak mineralocorticoid as an antagonist of potent mineralocorticoids.
    Sekihara H; Yazaki Y
    J Steroid Biochem Mol Biol; 1993 Apr; 45(4):235-8. PubMed ID: 8499332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta 1 inhibits aldosterone biosynthesis in cultured bovine zona glomerulosa cells.
    Gupta P; Franco-Saenz R; Mulrow PJ
    Endocrinology; 1993 Mar; 132(3):1184-8. PubMed ID: 8440178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extent of the adrenal influence upon renal electrolyte excretion in the healthy man on a normal diet, and its contribution to the renal changes on standing.
    MILLS JN; THOMAS S; WILLIAMSON KS
    J Endocrinol; 1962 Jan; 23():365-73. PubMed ID: 14474192
    [No Abstract]   [Full Text] [Related]  

  • 13. [RESEARCH ON THE MECHANISM OF THE DIURETIC ACTION OF TRIAMTERENE. I. RELATIONS TO THE PERIPHERAL INHIBITION OF ALDOSTERONE].
    AMBROSOLI S; BARONIO G; FERIOLI V; PENATI MR; PRATI G; SCARPIC L
    Minerva Nefrol; 1964; 11():25-9. PubMed ID: 14160627
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of the prolonged administration of aldosterone. Antagonistic action of glucocorticoids on the water-salt retention of aldosterone].
    LENZI S; AGNOLI GC; CARIANI A; LODI A; PINELLI G
    Boll Soc Ital Biol Sper; 1962 Mar; 38():241-6. PubMed ID: 14464047
    [No Abstract]   [Full Text] [Related]  

  • 15. Action of new steroids in blocking effects of aldosterone and desoxycorticosterone on salt.
    KAGAWA CM; CELLA JA; VAN ARMAN CG
    Science; 1957 Nov; 126(3281):1015-6. PubMed ID: 13486053
    [No Abstract]   [Full Text] [Related]  

  • 16. PHARMACOLOGICAL PROPERTIES OF A MINERALOCORTICOID ANTAGONIST (SC-14266).
    KAGAWA CM; BOUSKA DJ; ANDERSON ML; KROL WF
    Arch Int Pharmacodyn Ther; 1964 May; 149():8-24. PubMed ID: 14171763
    [No Abstract]   [Full Text] [Related]  

  • 17. Potassium prorenoate: a new steroidal aldosterone antagonist.
    Hofmann LM; Chinn LJ; Pedrera HA; Krupnick MI; Suleymanov OD
    J Pharmacol Exp Ther; 1975 Aug; 194(2):450-6. PubMed ID: 1151770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOME BIOLOGICAL PROPERTIES OF SYNTHETIC 18-HYDROXYTESTOSTERONE.
    KAGAWA CM; PAPPO R
    Endocrinology; 1964 Jun; 74():999-1000. PubMed ID: 14190645
    [No Abstract]   [Full Text] [Related]  

  • 19. Affinity of 18,19-dihydroxydeoxycorticosterone and 18-hydroxy-19-nor-deoxycorticosterone to aldosterone receptor and their mineralocorticoid activity.
    Okamoto M; Momoi K; Yamano T; Nakamura M; Odaguchi K; Shimizu T; Okada T; Terasawa T
    Biochem Int; 1983 Dec; 7(6):687-94. PubMed ID: 6237653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of aldosterone production by testosterone in male rats.
    Kau MM; Lo MJ; Wang SW; Tsai SC; Chen JJ; Chiao YC; Yeh JY; Lin H; Shum AY; Fang VS; Ho LT; Wang PS
    Metabolism; 1999 Sep; 48(9):1108-14. PubMed ID: 10484049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.